Stock Price
1.77
Daily Change
-0.19 -9.49%
Monthly
28.83%
Yearly
9.63%
Q1 Forecast
1.82

Geron reported $4.26M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Bio Techne USD 971K 386K Sep/2025
Cassava Sciences USD 1.17M 47K Sep/2025
Cytokinetics USD 10.25M 2.75M Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 15.92M 867K Sep/2025
Genmab DKK 25M 8M Jun/2025
Geron USD 4.26M 392K Sep/2025
Gilead Sciences USD 88M 15M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
MacroGenics USD 1.53M 114K Sep/2025
Novavax USD 303K 27K Dec/2021